Vitaglic MV Tablet

By Vitaglic MV

Rx

10 Tablet in a Strip

Composition icon

Composition

Voglibose(0.2mg) + Metformin(500mg) + Gliclazide(80mg)

Manufacturer - Vitabolik Pharma icon

Manufacturer - Vitabolik Pharma

7, siraj-ud-doula sarani, 2nd floor, kolkata: 700069, west bengal

Expires on or after icon

Expires on or after

January, 2026

About Vitaglic MV Tablet

Vitaglic MV Tablet is classified as an anti-diabetic medication, specifically designed to manage type 2 diabetes mellitus in adult patients. Type 2 diabetes is a chronic condition that impacts the body's ability to process glucose effectively. Individuals with type 2 diabetes either have insufficient insulin production or experience insulin resistance, leading to elevated blood sugar levels and symptoms like increased thirst, frequent urination, and heightened hunger. If left unmanaged, type 2 diabetes can result in severe complications such as skin infections, eye issues, nerve damage, kidney disease, hypertension, and even stroke.

The composition of Vitaglic MV Tablet includes a combination of three essential anti-diabetic drugs: Voglibose, Metformin, and Gliclazide. Voglibose functions as an alpha-glucosidase inhibitor, preventing the rapid breakdown of complex sugars into glucose after meals, thereby regulating sugar levels. Gliclazide, categorized as a 'sulfonylurea', enhances insulin release from the pancreas. Metformin, known as a 'biguanide', aids in reducing liver glucose production, delaying intestinal glucose absorption, and enhancing the body's response to insulin. Together, these medications work synergistically to prevent excessive increases in blood glucose levels, effectively managing diabetes.

It is crucial to maintain strict control over blood sugar levels to minimize the risk of diabetes-related complications. Vitaglic MV Tablet is most effective when complemented with lifestyle modifications such as weight loss, regular exercise, and a balanced diet. To optimize its benefits, it is recommended to take Vitaglic MV Tablet with food to prevent gastrointestinal disturbances and adhere to consistent daily dosing schedules. The dosage of Vitaglic MV Tablet should be determined by a healthcare provider based on individual needs and may require adjustments over time depending on blood sugar levels.

While Vitaglic MV Tablet offers therapeutic benefits, it also carries potential side effects, with hypoglycemia (low blood sugar levels) being the most common. Symptoms of hypoglycemia include dizziness, sweating, palpitations, hunger, and dry mouth. To mitigate the risk of hypoglycemia, it is important to avoid skipping meals and have a readily available source of sugar on hand. Additional side effects associated with Vitaglic MV Tablet may include changes in taste, nausea, diarrhea, stomach discomfort, headaches, and upper respiratory symptoms.

Individuals should exercise caution and avoid taking Vitaglic MV Tablet if diagnosed with diabetic ketoacidosis, type 1 diabetes mellitus, or severe kidney or liver disease. Precautions should be taken by informing healthcare providers of any existing heart conditions, pregnancy, or breastfeeding status before initiating treatment with Vitaglic MV Tablet. Regular monitoring of blood sugar levels and periodic blood tests to assess blood cell counts and liver function are advised to ensure optimal management of diabetes.


Benefits

Vitaglic MV Tablet offers a variety of benefits for individuals with diabetes. It is a unique combination of Voglibose, Metformin, and Gliclazide, three effective anti-diabetic drugs. Voglibose works by preventing the rapid increase in sugar levels post-meals by inhibiting the breakdown of complex sugars into simple sugars like glucose. Gliclazide, a sulfonylurea, helps in boosting insulin release from the pancreas. Metformin, a biguanide, aids in reducing glucose production in the liver, slowing down glucose absorption in the intestines, and enhancing the body's sensitivity to insulin.


By combining these three drugs, Vitaglic MV Tablet effectively controls blood glucose levels. This is crucial in managing diabetes and preventing its adverse effects on health. When taken as prescribed, Vitaglic MV Tablet plays a significant role in preventing blood sugar spikes and maintaining optimal glucose levels. To achieve the best results, it is recommended to complement the medication with a healthy lifestyle that includes weight management, regular exercise, and a balanced diet. This comprehensive approach can help individuals with diabetes effectively manage their condition and lead a better quality of life.


How to use the Vitaglic MV Tablet

When using Vitaglic MV Tablet, it is important to follow your doctor's instructions regarding the dose and duration. The tablet should be swallowed whole with water and taken with food. Do not crush, chew, or break the tablet before consuming it. By following these guidelines, you can ensure the effectiveness of the medicine and maximize its benefits for your health. If you have any questions or concerns about how to use Vitaglic MV Tablet, do not hesitate to consult your doctor or pharmacist for further clarification.


Uses of Vitaglic MV Tablet

Vitaglic MV Tablet is commonly used in the management of Type 2 Diabetes Mellitus. People with this condition can benefit from taking Vitaglic MV Tablet as part of their treatment plan. This tablet is specifically designed to help regulate blood sugar levels in those with Type 2 Diabetes Mellitus, aiding in better control of the condition. By including Vitaglic MV Tablet in their daily routine, individuals with Type 2 Diabetes Mellitus can potentially improve their overall health and well-being.


What conditions Vitaglic MV Tablet treats?

Vitaglic MV Tablet is commonly used for managing Diabetes Mellitus type 2. This condition occurs when the body either doesn't make enough insulin or becomes resistant to its effects, leading to high blood sugar levels. Symptoms may include fatigue, excessive thirst, blurry vision, and frequent urination. If left untreated, type 2 diabetes can result in various complications such as skin infections, eye issues, nerve damage, slow wound healing, kidney problems, high blood pressure, and stroke. It's crucial to monitor and manage blood sugar levels to prevent further health issues.


Should you consult a doctor?

It is crucial to seek medical attention if you experience persistent side effects or concerning symptoms while taking Vitaglic MV Tablet. Contact your doctor if you encounter unrelenting nausea, persistent hypoglycemia (low blood glucose levels), prolonged abdominal pain, or ongoing constipation. These symptoms may indicate a need for medical evaluation to ensure your health and well-being while using this medication. Remember, your doctor is there to help and can provide guidance and support in managing any side effects or concerns that may arise.


Side effects of Vitaglic MV Tablet

When taking Vitaglic MV Tablet, some side effects may occur, but most of them do not usually need medical attention. These side effects are usually temporary and go away as your body gets used to the medicine. However, if they persist or if you are concerned about them, it is advisable to consult your doctor. One potential side effect is nausea, which may cause discomfort. Another possible side effect is hypoglycemia, characterized by low blood glucose levels, which can lead to symptoms such as dizziness, sweating, palpitations, hunger pangs, dry mouth, and dry skin. Additionally, abdominal pain and constipation are also potential side effects that may occur while using Vitaglic MV Tablet.


Safety advice

scroll

liver

Vitaglic MV Tablet needs to be used carefully in individuals with liver concerns. It may require a dose adjustment, so it's crucial to consult your doctor before taking this medication. Typically, Vitaglic MV Tablet is initiated at a low dosage for people with mild to moderate liver issues. However, it is advised against using this tablet for patients with severe liver disease. Specifically, Vitaglic MV Tablet should be taken cautiously, particularly if there is a history of liver diseases or conditions. Your doctor may need to make adjustments to the dosage based on your liver health.

scroll

kidney

Take Vitaglic MV Tablet with caution if you have kidney disease. Adjustment of dose may be necessary. Avoid use in severe kidney disease. Regularly monitor kidney function tests while on this medication.

scroll

alcohol

It is not safe to drink alcohol while taking Vitaglic MV Tablet to prevent any negative effects. Avoid consuming alcohol with Vitaglic MV Tablet 0.2 Tablet 10's to stay safe from side-effects.

scroll

driving

Caution - Driving Your ability to drive may be affected by Vitaglic MV Tablet if you experience symptoms of low blood sugar such as sleepiness, shivering, palpitations, or sweating. Be cautious when driving and avoid it if these symptoms occur.

scroll

pregnancy

Vitaglic MV Tablet may not be safe to use during pregnancy. Animal studies have shown potential harm to the developing baby. Consult your doctor before using this tablet if you are pregnant.

scroll

breastfeeding

Vitaglic MV Tablet should be used with caution while breastfeeding. It is recommended to wait until the mother's treatment is finished and the drug is no longer in her system before breastfeeding. Vitaglic MV Tablet should only be used in nursing mothers if absolutely necessary. Consult your doctor for a thorough evaluation of the benefits and risks before using this medication.


Consumption warning before consuming Vitaglic MV Tablet

Before consuming Vitaglic MV Tablet, it is important to be aware of certain precautions. Some diabetic patients may experience a rare but serious condition known as lactic acidosis when taking this medication. This condition occurs when there is an accumulation of excessive lactic acid in the blood, requiring proper liver and kidney function to eliminate it. Individuals with kidney disease should avoid taking Vitaglic MV Tabletas indicated by a blood test. Additionally, this medication may lead to lower levels of vitamin B12, necessitating regular blood tests for monitoring. When used alongside or without insulin, Vitaglic MV Tablet can significantly decrease blood sugar levels, potentially requiring a reduction in insulin dosage under medical supervision. Lastly, it is advisable to undergo an annual check-up of thyroid-stimulating hormone (TSH) levels due to the possible impact of Vitaglic MV Tablet on TSH.


Disease interactions

When considering Vitaglic MV Tablet in the context of disease drug interactions, it is crucial to note that individuals with specific health conditions should avoid using this tablet. Patients with vitamin B12 deficiency, kidney problems, liver problems, cardiovascular disease, and low blood sugar levels (hypoglycemia) may experience a worsening of their condition if they take this tablet. Therefore, it is advisable for individuals with these health issues to avoid using Vitaglic MV Tablet to prevent any potential complications or negative effects.


Additional Information

Habit FormingNo
Chemical Class-
Therapeutic ClassANTI DIABETIC
Action Class-

FAQs


Disclaimer

The information provided on this website is to the best of our abilities to ensure it is accurate, reliable, and reviewed by a team of professionals. It should not be used to diagnose, prevent, or cure any health problem. The information presented here is not intended to create a doctor-patient relationship or replace a registered medical practitioner's advice, diagnosis, or treatment. The absence or provision of any information or warning regarding any medicine should not be assumed as an implied or explicit assurance of safety or efficacy. We highly recommend consulting your registered medical practitioner for all queries or doubts related to your medical condition. Do not ignore professional medical advice or delay seeking it based on the content encountered on our website. We intend to support, not replace, the doctor-patient relationship.

119.7

133

10% OFF

Inclusive of all taxes

Content verified by

chevron-right

Dr. Upasana Bhatia

MBBS - General Medicine

Last update on 01-Oct-2024